Micro- and Nanotechnology in Vaccine Development

Nonfiction, Health & Well Being, Medical, Medical Science, Immunology, Science & Nature, Technology, Engineering, Chemical & Biochemical
Cover of the book Micro- and Nanotechnology in Vaccine Development by , Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9780323400299
Publisher: Elsevier Science Publication: September 20, 2016
Imprint: Elsevier Language: English
Author:
ISBN: 9780323400299
Publisher: Elsevier Science
Publication: September 20, 2016
Imprint: Elsevier
Language: English

This book provides a comprehensive overview of how use of micro- and nanotechnology (MNT) has allowed major new advance in vaccine development research, and the challenges that immunologists face in making further progress.

MNT allows the creation of particles that exploit the inherent ability of the human immune system to recognize small particles such as viruses and toxins. In combination with minimal protective epitope design, this permits the creation of immunogenic particles that stimulate a response against the targeted pathogen. The finely tuned response of the human immune system to small particles makes it unsurprising that many of the lead adjuvants and vaccine delivery systems currently under investigation are based on nanoparticles.

  • Provides a comprehensive and unparalleled overview of the role of micro- and nanotechnology in vaccine development
  • Allows researchers to quickly familiarize themselves with the broad spectrum of vaccines and how micro- and nanotechnologies are applied to their development
  • Includes a combination of overview chapters setting out general principles, and focused content dealing with specific vaccines, making it useful to readers from a variety of disciplines
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book provides a comprehensive overview of how use of micro- and nanotechnology (MNT) has allowed major new advance in vaccine development research, and the challenges that immunologists face in making further progress.

MNT allows the creation of particles that exploit the inherent ability of the human immune system to recognize small particles such as viruses and toxins. In combination with minimal protective epitope design, this permits the creation of immunogenic particles that stimulate a response against the targeted pathogen. The finely tuned response of the human immune system to small particles makes it unsurprising that many of the lead adjuvants and vaccine delivery systems currently under investigation are based on nanoparticles.

More books from Elsevier Science

Cover of the book Clay-Polymer Nanocomposites by
Cover of the book Hazards, Risks, and Disasters in Society by
Cover of the book Storm and Cloud Dynamics by
Cover of the book Digital Integrated Circuit Design Using Verilog and Systemverilog by
Cover of the book Introduction to Infrared and Raman Spectroscopy by
Cover of the book Hypobaric Storage in Food Industry by
Cover of the book Micropatterning in Cell Biology, Part A by
Cover of the book Physiological Systems in Insects by
Cover of the book Future Directions in Biocatalysis by
Cover of the book Solar Energy Conversion by
Cover of the book The HDL Handbook by
Cover of the book Progress in Optics by
Cover of the book Navigating Academia: A Guide for Women and Minority STEM Faculty by
Cover of the book Stereoregular Polymers and Stereospecific Polymerizations by
Cover of the book Sizing in Clothing by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy